Graves' orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal
manifestation of Graves' disease, the most common cause of hyperthyroidism. GO affects …

Abstract Introduction Graves' orbitopathy (GO), thyroid dermopathy (also called pretibial
myxedema) and acropachy are the extrathyroidal manifestations of Graves' disease. They …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of …

Summary Objective Management of Graves' disease (GD) in Europe was published in 1987.
Aim of this survey was to provide an update on clinical practice in Europe, and to compare it …

This document provides the new EANM guideline on radioiodine therapy of benign thyroid
disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners …

Autoimmune thyroid diseases (AITDs) include a wide spectrum of thyroid diseases affecting
more commonly women than men. The most frequent forms are Graves' Disease (GD) and …

Thyroid dermopathy that occurs in 4–13% of patients with Graves' ophthalmopathy is an
extrathyroidal manifestation of Graves' disease. Thyroid acropachy commonly presents with …

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas.
Although progress has been made in our understanding of the pathogenesis of the disease …

Background The relation between therapy options for Graves' disease (GD) and the course
of Graves' ophthalmopathy (GO) are still controversial. Our aim was to compare the …

The medical treatment of Graves' orbitopathy (GO) is usually reserved to moderate to severe
disease. Steroids have been widely employed and possess anti-inflammatory activity, but …